The “Borderline” Renal Allograft Biopsy in the Era of Molecular Diagnostics: A Sampling Conundrum?

Authors


Parmjeet Randhawa, randhawapa@upmc.edu

Abstract

The author comments on the potential causes and clinical significance of discrepancies between conventional histologic and modern molecular approaches for evaluating renal allograft biopsies. See article by de Freitas et al on page 191.

Ancillary